Physician

Abdallah Halim El-Habr

According to 2025 Medicare claims, Abdallah El-Habr (NPI: 1689767915) practices pulmonary disease in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is ABINGTON MEMORIAL HOSPITAL (NPI: 1487028262; TIN: 231352152) and primary practice location at 19001-3720. El-Habr is affiliated with the Delaware Valley ACO (ACO ID: A2024), participating under the MSSP model.

El-Habr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 593 traditional Medicare patients, billed 1,731 HCPCS/CPT codes, and received $133,884 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,485 prescription claims across 390 beneficiaries totaling $920,910 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 807 claims. Open Payments data shows 25 records totaling $522. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $395,725 to $133,884. In contrast, Part D prescription costs have risen steadily, from $65,676 to $920,910. For DME billing, this smaller-volume category moved sharply higher in recent years, from $18,671 to $31,126.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	879	5,042	$395,725
2016	655	3,367	$262,033
2017	454	1,354	$139,798
2018	416	893	$106,652
2019	512	1,362	$136,463
2020	496	1,587	$165,103
2021	673	1,945	$175,554
2022	638	1,949	$171,775
2023	660	1,794	$148,727
2024	593	1,731	$133,884

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	168	638	$65,676
2016	163	503	$78,998
2017	61	164	$29,563
2018	30	66	$3,767
2019	25	59	$13,745
2020	72	273	$74,461
2021	213	925	$312,443
2022	259	1,343	$589,215
2023	308	1,702	$711,033
2024	390	2,485	$920,910

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	15	308	$20,812
2016	42	377	$16,664
2017	N/R	148	$4,035
2018	N/R	22	$774
2019	N/R	N/R	N/R
2020	N/R	53	$1,761
2021	12	199	$6,143
2022	32	430	$12,783
2023	98	546	$17,969
2024	191	807	$28,159

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	143	176	$96
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	163	319	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	107	130	$68
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	109	188	$63
94729	Test to examine how well the lungs exchange gases	115	117	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	385	13,500	$280,829
Ofev	Nintedanib Esylate	13	390	$173,850
Breo Ellipta	Fluticasone/Vilanterol	260	10,320	$131,065
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	83	2,970	$60,516
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	103	3,930	$58,359

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	20	121	$8,423
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	20	54	$3,057
E1392	Portable oxygen concentrator, rental	Y	13	81	$2,738
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	17	$2,385
A7031	Face mask interface, replacement for full face mask, each	N	N/R	21	$1,805

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$522	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdallah Halim El-Habr?

Tedicare shows public-source Medicare data for Abdallah Halim El-Habr (NPI 1689767915), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdallah Halim El-Habr have ACO affiliation data?

Abdallah Halim El-Habr is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024).

What billing organization is linked to Abdallah Halim El-Habr?

Abdallah Halim El-Habr is linked to ABINGTON MEMORIAL HOSPITAL (billing NPI 1487028262) in the available physician profile data.

Does Abdallah Halim El-Habr have Open Payments data?

Abdallah Halim El-Habr has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.